Últimos Artículos de Lancet Diabetes & Endocrinology
- [Comment] Endpoints for clinical trials in type 1 diabetes drug development
- [Correspondence] Vitamin D supplements and future fracture risk among Mongolian schoolchildren
- [Comment] The Human Insulin Thermal Solution project—a private sector initiative to address the thermostability of insulin
- [Correspondence] Environmental chemical obesogens, what can we do?
- [Comment] Food additive emulsifiers: a new risk factor for type 2 diabetes?
- [In Focus] Anand Hardikar: a scientific nomad searching for the truth
- [Articles] Food additive emulsifiers and the risk of type 2 diabetes: analysis of data from the NutriNet-Santé prospective cohort study
- [Correspondence] Rethinking the label anti-obesity medication
- [Correspondence] Vitamin D supplements and future fracture risk among Mongolian schoolchildren – Author's reply
- [Editorial] Earth Day: time for transformational change
- [Review] Endocrine health in survivors of adult-onset cancer
- [In Focus] Direct-to-consumer services: improving access to care for people with diabetes and obesity
- [Articles] Associations of the glycaemic index and the glycaemic load with risk of type 2 diabetes in 127 594 people from 20 countries (PURE): a prospective cohort study
- [Comment] Glycaemic index as part of the diabetes prevention strategy
- [Comment] Type 1 diabetes: heterogeneity in heritability
- [Articles] Familial aggregation and heritability of childhood-onset and adult-onset type 1 diabetes: a Swedish register-based cohort study
- [Articles] Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis
- [Comment] How clinically relevant is statin-induced diabetes?
- [Comment] Disparities in fragility fracture and osteoporosis care in Africa
- [Personal View] Tight versus liberal blood-glucose control in the intensive care unit: special considerations for patients with diabetes